Low-dose edoxaban in patients 80 years and older with atrial fibrillation and dose-reduction criteria: randomized analysis between edoxaban 15 mg and 30 mg
Event:
ESC Congress 2025
Topic:
Cardiovascular Disease in the Elderly
Session:
Management of cardiovascular disease in older adults